Fundz

Oncternal Therapeutics, Inc. reported raising $3.46 Million in an initial SEC Form D filing, from an offering of $3.46 Million

PRIVATEAug 03, 2020

Amount Raised

$3.46 Million

$3.46 Million sold, per SEC Form D (first sale Aug 3, 2020)

Round Type

Seed

San DiegoBiotechnology

Quick answer

Oncternal Therapeutics, Inc. raised $3.46 Million in a Seed round, dated August 3, 2020. Oncternal Therapeutics, Inc. is based in San Diego, California, United States.

How much did Oncternal Therapeutics, Inc. raise?
Oncternal Therapeutics, Inc. raised $3.46 Million in a Seed round on August 3, 2020.
What does Oncternal Therapeutics, Inc. do?
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.
Where is Oncternal Therapeutics, Inc. based and how big is it?
Oncternal Therapeutics, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Oncternal Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Palleon Pharmaceuticals Inc. raised $100M on September 17, 2020.
  • Finch Therapeutics Group, Inc. raised $88M on September 17, 2020.
  • BioNTech raised $250M on September 17, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
  • AgroSpheres raised $485K (Seed) on September 17, 2020.
  • Cyrus Biotechnology, Inc. raised $1.1M (Seed) on September 17, 2020.

Who to call at Oncternal Therapeutics, Inc., and when

A new round usually means Oncternal Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oncternal Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oncternal Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oncternal Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oncternal Therapeutics, Inc.

Location

12230 El Camino Real

San Diego, California, United States

About

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oncternal Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Oncternal Therapeutics, Inc.'s next move

See what Strategic adds

Oncternal Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.